Clinical Trial Update: Clinical Utility and Safety of Human Umbilical Cord Mesenchymal Stem Cell Secretome in Drug Resistant Epilepsy Single Center, Non-randomized, Phase I Clinical Trial [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial assessing the safety and potential utility of human umbilical cord mesenchymal stem cell secretome for drug-resistant epilepsy, sponsor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-resistant Epilepsy
• Epilepsy

Drugs mentioned

• Human Umbilical Cord Mesenchymal Stem Cell Secretome (mesenchymal stem cell secretome)

Snippet

Sponsor: Baermed | Conditions: Epilepsy, Drugs Resistant Epilepsy | Phase 1 | Status: NOT_YET_RECRUITING